BCAB BioAtla Inc

$BCAB Remember the good ole days when BioGrifters of failed biotech companies would just use the go-to multilevel scam of switching to crypto (when it was hot) to try to salvage their faux biotech company that was 90-99% off its historic highs? Now, I guess the buzz word du jour - i mean, du an, is "A.I." so I should probably update my fictitious (but hopefully for not much longer) book: The BioGrifter's Wealth Transfer Playbook to reflect the "there's a new scam in town". Let's use A.I. to do some pretend math to convince more saps that our drug that either does not work or is not competitive actually could work.

$BCAB Exuma has agreeed to pay Bioatla $250,000 to satisfy their future royalty obligations. Doesn't appear to encompass any late stage assets. They did the same with Context as we all know. Bioatla is cleaning up its legacy licensing arrangements. Himalaya's CFO is moving over to Inversagen AI. So I would imagine we will hear something shortly regarding the Himalaya/Bioatla partnership being ammended or terminated. I think it's the last piece to clean up. Still trying to figure out exactly what is happening here. It's intriguing.

$BCAB I have no idea if Inversagen AI is funded or not. Seems odd to me that its Chairman, Jay Short, would go live with a website that makes certain representations about BCAB assets while he remains CEO of BCAB, but it DOES look like the AI-Biotech space is heating up. From today's WSJ: AI Biotech Enveda Doubles in Value to $2 Billion Backed by a former J&J CEO, the startup plans to advance its drug candidates into late-stage trials....

$BCAB like i stated many times. Biggest fraud company. Can you see all Bioatla assets magical disappear into Jay Scott other companies. Inversagon and Himalaya. If you buy stocks now in this $2M market cap. Then you are a idiot and you will lose it all. It is not in interest of Jay Scott to save Bioatla. He just steal the assets for free and soon all the intellectual Property for pennies on the dollar. There are no way you can defend this company or its management longer. Corrupt ad the President

$BCAB looks to have an oral presentation at PEGS Europe on Nov 17 on its EpCAM program? Been a year since last update and many patients were still on treatment or just started. It's what got market excited for a second

$BCAB what a fraud.. only idiots keep there shares. And totally idiots buy. There are no value here. The one telling you that. Is the one who wan't to sell. Marked cap lower then a value of apartment tell you all you need to know

$BCAB One thing I find particularly interesting on the Inversagen AI website is this comment. "Lloyd's of London has agreed to insure clinical trials on the strength of the same risk analysis." I have actually never seen this in any of the clinical stage biotechs I have followed. So I guess that whoever funds this trial has very little risk. Am I seeing this right? Lloyd's actually pays back the financer if the clinical trial fails? Weird. Cool, but weird.🤔

$BCAB if they do a deal by EOY, as the filing/new website suggests, probably 5-10x upside from here depending on how much they get for Oz-V. $2M market cap and last year were supposed to get $40M upfront for 35% of the drug, so over $100M valuation for Oz-V alone

$BCAB "Inversagen AI was formed in 2025 to combine two proven bodies of work: BioAtla's patented antibody technology and GATC Health's predictive AI. Together they give us ten drug assets, a Phase 3 oncology programme, and a pipeline aimed at the biology of aging itself." Sounds like Inversagen will buy BCAB and all their assets/IP soon

$BCAB what are the latest proposed exec bonuses for driving this into the ground? Bonuses for bankruptcy, hilarious incentive plan.

$BCAB this current hoopla is welcomed and frankly past due. Let’s hope for the best but I do have concerns. Supposedly Jay is working out a deal to sell assets to a new llc that he’s on the board of. Is there anyone at this point (other than ambulance chasing lawyers) looking out for the stock holders to make sure this does not turn into a transferring assets from one pocket to the other? Regardless at least it should be interesting the next few weeks

$BCAB now that sievers left it’s down to Jay and a junior accountant with a CFO title. Next up is a sale of desks and computer equipment in front of of their office…